Detailed information for compound 982179

Basic information

Technical information
  • TDR Targets ID: 982179
  • Name: 1-[[4-(1,3-benzothiazol-2-yloxy)phenyl]methyl ]piperidine-4-carboxylic acid
  • MW: 368.449 | Formula: C20H20N2O3S
  • H donors: 1 H acceptors: 3 LogP: 1.82 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: OC(=O)C1CCN(CC1)Cc1ccc(cc1)Oc1nc2c(s1)cccc2
  • InChi: 1S/C20H20N2O3S/c23-19(24)15-9-11-22(12-10-15)13-14-5-7-16(8-6-14)25-20-21-17-3-1-2-4-18(17)26-20/h1-8,15H,9-13H2,(H,23,24)
  • InChiKey: BUZBVOKDNAZIIM-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 1-[[4-(1,3-benzothiazol-2-yloxy)phenyl]methyl]-4-piperidinecarboxylic acid
  • 1-[4-(1,3-benzothiazol-2-yloxy)benzyl]isonipecotic acid

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens potassium voltage-gated channel, subfamily H (eag-related), member 2 Starlite/ChEMBL References
Homo sapiens leukotriene A4 hydrolase Starlite/ChEMBL References
Mus musculus leukotriene A4 hydrolase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma mansoni voltage-gated potassium channel Get druggable targets OG5_128858 All targets in OG5_128858
Brugia malayi Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog Get druggable targets OG5_128858 All targets in OG5_128858
Loa Loa (eye worm) leukotriene A4 hydrolase Get druggable targets OG5_129538 All targets in OG5_129538
Candida albicans leukotriene A4 hydrolase/leucyl aminopeptidase Get druggable targets OG5_129538 All targets in OG5_129538
Trichomonas vaginalis voltage and ligand gated potassium channel, putative Get druggable targets OG5_128858 All targets in OG5_128858
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_128858 All targets in OG5_128858
Schistosoma mansoni leukotriene A4 hydrolase (M01 family) Get druggable targets OG5_129538 All targets in OG5_129538
Schistosoma mansoni voltage-gated potassium channel Get druggable targets OG5_128858 All targets in OG5_128858
Schistosoma japonicum ko:K04910 potassium voltage-gated channel, Eag-related subfamily H, member 7, putative Get druggable targets OG5_128858 All targets in OG5_128858
Candida albicans leukotriene A4 hydrolase/leucyl aminopeptidase Get druggable targets OG5_129538 All targets in OG5_129538
Schistosoma japonicum ko:K04910 potassium voltage-gated channel, Eag-related subfamily H, member 7, putative Get druggable targets OG5_128858 All targets in OG5_128858
Echinococcus granulosus potassium voltage gated channel subfamily H Get druggable targets OG5_128858 All targets in OG5_128858
Loa Loa (eye worm) voltage and ligand gated potassium channel Get druggable targets OG5_128858 All targets in OG5_128858
Echinococcus multilocularis leukotriene A 4 hydrolase Get druggable targets OG5_129538 All targets in OG5_129538
Schistosoma japonicum ko:K01254 leukotriene-A4 hydrolase [EC3.3.2.6], putative Get druggable targets OG5_129538 All targets in OG5_129538
Echinococcus granulosus leukotriene A 4 hydrolase Get druggable targets OG5_129538 All targets in OG5_129538
Trichomonas vaginalis voltage and ligand gated potassium channel, putative Get druggable targets OG5_128858 All targets in OG5_128858
Schistosoma japonicum Potassium voltage-gated channel subfamily H member 2, putative Get druggable targets OG5_128858 All targets in OG5_128858
Echinococcus multilocularis potassium voltage gated channel subfamily H Get druggable targets OG5_128858 All targets in OG5_128858

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Leishmania major aminopeptidase-like protein,metallo-peptidase, Clan MA(E), Family M1 leukotriene A4 hydrolase 611 aa 513 aa 24.0 %
Leishmania major aminopeptidase-like protein,metallo-peptidase, Clan MA(E), Family M1 leukotriene A4 hydrolase 611 aa 508 aa 22.8 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Toxoplasma gondii aminopeptidase n, putative 0.003 0.0307 0.5
Echinococcus granulosus puromycin sensitive aminopeptidase 0.003 0.0307 0.0307
Mycobacterium ulcerans aminopeptidase N PepN 0.003 0.0307 0.5
Echinococcus granulosus puromycin sensitive aminopeptidase 0.003 0.0307 0.0307
Schistosoma mansoni leukotriene A4 hydrolase (M01 family) 0.0558 1 1
Onchocerca volvulus 0.003 0.0307 0.5
Trypanosoma brucei metallo-peptidase, Clan MA(E) Family M1 0.003 0.0307 0.5
Plasmodium falciparum M1-family alanyl aminopeptidase 0.003 0.0307 0.5
Loa Loa (eye worm) hypothetical protein 0.003 0.0307 0.0307
Schistosoma mansoni aminopeptidase PILS (M01 family) 0.003 0.0307 0.0307
Leishmania major aminopeptidase, putative,metallo-peptidase, Clan MA(E), Family M1 0.003 0.0307 0.5
Loa Loa (eye worm) hypothetical protein 0.003 0.0307 0.0307
Trypanosoma cruzi aminopeptidase, putative 0.003 0.0307 0.5
Brugia malayi hypothetical protein 0.0256 0.447 1
Echinococcus multilocularis potassium voltage gated channel subfamily H 0.0045 0.0581 0.0581
Loa Loa (eye worm) hypothetical protein 0.003 0.0307 0.0307
Brugia malayi Peptidase family M1 containing protein 0.003 0.0307 0.0687
Brugia malayi hypothetical protein 0.003 0.0307 0.0687
Trypanosoma cruzi metallo-peptidase, clan MA(E), family M1, putative 0.003 0.0307 0.5
Toxoplasma gondii aminopeptidase N protein 0.003 0.0307 0.5
Echinococcus multilocularis puromycin sensitive aminopeptidase 0.003 0.0307 0.0307
Trypanosoma cruzi puromycin-sensitive aminopeptidase-like protein, putative 0.003 0.0307 0.5
Toxoplasma gondii aminopeptidase N, putative 0.003 0.0307 0.5
Plasmodium falciparum M1-family alanyl aminopeptidase, putative 0.003 0.0307 0.5
Plasmodium vivax M1-family alanyl aminopeptidase, putative 0.003 0.0307 0.5
Loa Loa (eye worm) voltage and ligand gated potassium channel 0.0045 0.0581 0.0581
Echinococcus multilocularis puromycin sensitive aminopeptidase 0.003 0.0307 0.0307
Leishmania major aminopeptidase, putative,metallo-peptidase, Clan MA(E), Family M1 0.003 0.0307 0.5
Trypanosoma brucei aminopeptidase, putative 0.003 0.0307 0.5
Schistosoma mansoni cytosol alanyl aminopeptidase (M01 family) 0.003 0.0307 0.0307
Plasmodium vivax M1-family alanyl aminopeptidase, putative 0.003 0.0307 0.5
Echinococcus multilocularis Peptidase M1, membrane alanine aminopeptidase, N terminal 0.003 0.0307 0.0307
Trypanosoma cruzi aminopeptidase, putative 0.003 0.0307 0.5
Trypanosoma cruzi Aminopeptidase M1, putative 0.003 0.0307 0.5
Echinococcus multilocularis puromycin sensitive aminopeptidase 0.003 0.0307 0.0307
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0042 0.0527 1
Echinococcus granulosus aminopeptidase N 0.003 0.0307 0.0307
Schistosoma mansoni voltage-gated potassium channel 0.0049 0.0656 0.0656
Onchocerca volvulus 0.003 0.0307 0.5
Echinococcus multilocularis puromycin sensitive aminopeptidase 0.003 0.0307 0.0307
Loa Loa (eye worm) TATA binding protein associated factor 0.003 0.0307 0.0307
Schistosoma mansoni Tata binding protein associated factor (M01 family) 0.003 0.0307 0.0307
Loa Loa (eye worm) peptidase family M1 containing protein 0.003 0.0307 0.0307
Trypanosoma cruzi metallo-peptidase, clan MA(E), family M1, putative 0.003 0.0307 0.5
Brugia malayi TATA binding protein associated factor 0.003 0.0307 0.0687
Brugia malayi hypothetical protein 0.003 0.0307 0.0687
Echinococcus multilocularis leukotriene A 4 hydrolase 0.0558 1 1
Echinococcus granulosus potassium voltage gated channel subfamily H 0.0045 0.0581 0.0581
Brugia malayi Peptidase family M1 containing protein 0.003 0.0307 0.0687
Onchocerca volvulus 0.003 0.0307 0.5
Trypanosoma cruzi puromycin-sensitive aminopeptidase-like protein, putative 0.003 0.0307 0.5
Loa Loa (eye worm) hypothetical protein 0.0039 0.0473 0.0473
Entamoeba histolytica aminopeptidase, putative 0.003 0.0307 0.5
Loa Loa (eye worm) leukotriene A4 hydrolase 0.0558 1 1
Schistosoma mansoni aminopeptidase A (M01 family) 0.003 0.0307 0.0307
Echinococcus granulosus puromycin sensitive aminopeptidase 0.003 0.0307 0.0307
Leishmania major aminopeptidase-like protein,metallo-peptidase, Clan MA(E), Family M1 0.003 0.0307 0.5
Schistosoma mansoni voltage-gated potassium channel 0.0049 0.0656 0.0656
Trypanosoma brucei Aminopeptidase M1, putative 0.003 0.0307 0.5
Trypanosoma brucei Aminopeptidase M1, putative 0.003 0.0307 0.5
Echinococcus multilocularis puromycin sensitive aminopeptidase 0.003 0.0307 0.0307
Trypanosoma cruzi metallo-peptidase, Clan MA(E) Family M1 0.003 0.0307 0.5
Loa Loa (eye worm) aminopeptidase N 0.003 0.0307 0.0307
Brugia malayi Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog 0.0045 0.0581 0.1299
Echinococcus granulosus puromycin sensitive aminopeptidase 0.003 0.0307 0.0307
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0042 0.0527 1
Echinococcus multilocularis aminopeptidase N 0.003 0.0307 0.0307
Echinococcus granulosus puromycin sensitive aminopeptidase 0.003 0.0307 0.0307
Mycobacterium ulcerans aminopeptidase N PepN 0.003 0.0307 0.5
Brugia malayi Peptidase family M1 containing protein 0.003 0.0307 0.0687
Leishmania major puromycin-sensitive aminopeptidase-like protein,metallo-peptidase, Clan MA(E), Family M1 0.003 0.0307 0.5
Echinococcus granulosus puromycin sensitive aminopeptidase 0.003 0.0307 0.0307

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 11 nM Inhibition of human recombinant leukotriene A4 hydrolase by enzyme immunoassay ChEMBL. 18588282
IC50 (binding) = 88 nM Inhibition of leukotriene A4 hydrolase activity in CD1 mouse whole blood assessed as A-23187-stimulated LTB4 production after 15 mins by enzyme immunoassay ChEMBL. 18588282
IC50 (binding) > 10 uM Inhibition of dofetilide binding to human ERG by patch clamp assay ChEMBL. 23127888
IC50 (binding) > 30 uM Displacement of [3H]astemizole from human ERG potassium channel expressed in HEK293 cell membrane ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human adenosine A1 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human adenosine A3 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human beta 1 adrenergic receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human AT1 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human ETA receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human bradykinin B2 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human dopamine D1 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human GAL2 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human CXCR2 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human MC4 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human substance NK2 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human neuropeptide Y1 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human neuropeptide Y2 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human NTS1 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human kappa opioid receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human mu opioid receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human ORL1 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of 5HT1B receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human 5HT2A receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human 5HT5A receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human 5HT7 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human VIP1 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human NET at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human dopamine D2 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human CCR1 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of histamine H2 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human muscarinic M1 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human muscarinic M2 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human muscarinic M3 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human neuromedin K receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human 5HT1A receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human 5HT3 receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human vasopressin V1a receptor at 1 uM ChEMBL. 18588282
Inhibition (binding) < 10 % Inhibition of human DAT at 1 uM ChEMBL. 18588282
Inhibition (binding) = 20 % Inhibition of human DAT ChEMBL. 18588282

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

2 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.